GB60 - Acute Kidney Injury: Complete ICD-11 Coding Guide

1. Introduction

Acute kidney injury (AKI) represents one of the most frequent nephrological emergencies in hospital clinical practice, characterized by a sudden and potentially reversible deterioration of renal function. This condition manifests through specific laboratory alterations and reductions in urine output, and may progress from mild and self-limited presentations to critical situations requiring immediate renal replacement therapy.

The clinical relevance of acute kidney injury extends beyond the renal system in isolation, since this condition frequently complicates the course of various other acute pathologies, including sepsis, circulatory shock, severe dehydration, drug intoxications, and major surgical procedures. Epidemiological studies demonstrate that AKI is associated with significant increase in hospital morbidity and mortality, prolongation of length of stay, and substantial elevation of healthcare costs.

The prevalence of acute kidney injury varies according to the clinical context, being particularly elevated in intensive care units, where it may affect a considerable proportion of critically ill patients. In general wards, the incidence is lower, but still represents a relevant public health problem, especially in vulnerable populations such as elderly patients, diabetics, and those with prior chronic kidney disease.

Precise coding of acute kidney injury using the GB60 code from ICD-11 is critical for multiple reasons: it enables appropriate epidemiological tracking of this condition, facilitates analysis of clinical outcomes, aids in hospital resource planning, contributes to healthcare quality studies, and ensures appropriate reimbursement by health systems. Inadequate documentation may result in underreporting of cases, hindering the true understanding of the impact of this condition.

2. Correct ICD-11 Code

The code GB60 from the International Classification of Diseases, 11th Revision (ICD-11), specifically identifies acute kidney injury, a condition characterized by an abrupt decline in renal function.

Code: GB60

Official description: Acute kidney injury

Parent category: Kidney failure

The official definition established by ICD-11 for acute kidney injury is based on objective and measurable criteria: an increase in serum creatinine of 0.3 mg/dl or more within a 48-hour period; or an increase in serum creatinine of 1.5 times or more above the baseline value, which is known or presumed to have occurred within 7 days; or urine output less than 0.5 ml/kg/h for 6 hours or more.

These diagnostic criteria are grounded in the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines, widely accepted by the international nephrology community. The use of objective and quantifiable parameters facilitates precise identification of cases, reducing diagnostic subjectivity and allowing epidemiological comparisons between different institutions and geographic regions.

It is important to highlight that code GB60 encompasses all forms of acute kidney injury, regardless of the underlying etiology, whether prerenal, intrinsic renal, or postrenal. Etiological classification can be complemented with additional codes when necessary to specify the precipitating cause.

3. When to Use This Code

The GB60 code should be applied in specific clinical situations where the established diagnostic criteria are clearly present. Below, we present detailed practical scenarios:

Scenario 1: Postoperative patient with creatinine elevation

A patient who underwent major abdominal surgery presents, on the second postoperative day, serum creatinine of 2.1 mg/dl, while the preoperative value was 1.0 mg/dl. The increase of 1.1 mg/dl exceeds the criterion of 0.3 mg/dl in 48 hours, configuring acute kidney injury. In this case, GB60 is the appropriate code, and may be complemented with a code for the underlying cause (hypovolemia, perioperative hypotension, etc).

Scenario 2: Patient with sepsis and oliguria

A patient admitted with a diagnosis of pneumonia complicated by sepsis develops urine output of 25 ml/hour, weighing 70 kg. Calculating 0.36 ml/kg/h, this value is below the criterion of 0.5 ml/kg/h maintained for 6 consecutive hours. Even if creatinine has not yet risen significantly, the oliguria criterion alone justifies GB60 coding.

Scenario 3: Severe dehydration in elderly patient

An elderly patient is admitted with acute gastroenteritis, severe dehydration, and serum creatinine of 3.2 mg/dl. Recent outpatient records show baseline creatinine of 1.2 mg/dl. The increase of 2.67 times the baseline value, occurring presumably over the last few days, characterizes AKI according to the criterion of elevation of 1.5 times or more in 7 days.

Scenario 4: Rhabdomyolysis with renal injury

A trauma victim with crush syndrome develops rhabdomyolysis, evidenced by extremely elevated CPK and myoglobinuria. Serum creatinine rises from 0.9 mg/dl to 2.5 mg/dl in 36 hours. The GB60 code is applicable, and may be complemented with a specific code for rhabdomyolysis.

Scenario 5: Drug-induced nephrotoxicity

A patient using nonsteroidal anti-inflammatory drug for chronic pain presents progressive elevation of creatinine from 1.1 mg/dl to 2.8 mg/dl over 5 days. The documentation of previously normal renal function and the temporal relationship with medication use characterize AKI, justifying GB60 with an additional code for adverse drug effect.

Scenario 6: Acute urinary obstruction

A patient with prostatic hyperplasia develops acute urinary retention with significant bladder distension. After 12 hours of complete anuria, serum creatinine rises from 1.3 mg/dl to 2.0 mg/dl. The criterion of extreme oliguria (anuria) and creatinine elevation justify GB60, complemented by a code for the obstructive cause.

4. When NOT to Use This Code

It is fundamental to differentiate situations where GB60 is not appropriate, avoiding incorrect coding:

Stable chronic kidney insufficiency: Patients with known chronic kidney disease, maintaining chronically elevated creatinine without recent acute deterioration, should be coded with GB61 (Chronic kidney insufficiency), not GB60. The distinction is based on the absence of acute changes in renal parameters.

Transient elevations without complete criteria: Discrete increases in creatinine that do not reach the established limits (less than 0.3 mg/dl in 48 hours or less than 1.5 times baseline) do not constitute AKI by official criteria. These situations may represent laboratory variations or subclinical renal dysfunction that do not justify GB60.

Chronic kidney disease with acute exacerbation: When a patient with previous chronic renal insufficiency presents with acute worsening superimposed, technically there is AKI superimposed on CKD. In these cases, both codes may be necessary (GB60 and GB61), with clear documentation of the underlying chronic condition and the superimposed acute deterioration.

Isolated urinary changes without renal dysfunction: Short-duration oliguria (less than 6 hours) or urinary changes without repercussion on renal function markers do not satisfy the criteria for GB60. For example, temporary reduction in urine output due to mild dehydration that resolves quickly with hydration.

Pseudorenal insufficiency: Situations where there is creatinine elevation due to increased production (use of creatine supplements, extreme high-protein diet) or laboratory interference, without true renal dysfunction, should not be coded as GB60. Global clinical evaluation is essential.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first essential step is to objectively verify whether diagnostic criteria are present. Obtain current and previous serum creatinine values, calculating the time interval and magnitude of elevation. Check whether there is an increase of 0.3 mg/dl or more within 48 hours. Alternatively, compare with known or presumed baseline value: is there a 1.5-fold or greater elevation within 7 days?

Simultaneously, assess urine output. Calculate urine volume per kilogram of body weight per hour. Document whether there was a period of 6 hours or more with output less than 0.5 ml/kg/h. Remember that only one of the criteria (creatinine or urine output) is sufficient for diagnosis.

Necessary instruments include: serial serum creatinine measurements, precise urine output records (strict fluid balance), patient's current body weight, and ideally, baseline values of previous renal function.

Step 2: Verify Specifiers

After confirming the diagnosis of AKI, determine severity according to KDIGO classification. Stage 1 is characterized by creatinine increase of 1.5-1.9 times baseline or increase of 0.3 mg/dl, or urine output less than 0.5 ml/kg/h for 6-12 hours. Stage 2 involves increase of 2.0-2.9 times baseline or urine output less than 0.5 ml/kg/h for 12 hours or more. Stage 3 includes increase of 3.0 times baseline or creatinine equal to or greater than 4.0 mg/dl, or need for renal replacement therapy, or urine output less than 0.3 ml/kg/h for 24 hours or anuria for 12 hours.

Identify the etiological classification: prerenal (hypovolemia, hypotension, low cardiac output states), intrinsic renal (acute tubular necrosis, acute glomerulonephritis, acute interstitial nephritis), or postrenal (urinary tract obstruction). This information may require additional codes.

Step 3: Differentiate from Other Codes

The main differentiation is with GB61 - Chronic kidney disease. The fundamental distinction is based on temporality: GB60 refers to acute deterioration (days to weeks) while GB61 denotes established and persistent renal dysfunction (months to years). Patients with known CKD who present with acute worsening may receive both codes, with GB60 reflecting the acute component.

Other differential codes include those for specific causes that may present with secondary renal dysfunction. In these cases, GB60 may be used as an additional code to characterize the renal complication.

Step 4: Required Documentation

Adequate documentation should include:

Mandatory checklist:

Serum creatinine values with precise dates and times
Known or estimated baseline creatinine
Detailed urine output record with times
Patient's body weight
Description of clinical presentation
Etiological investigation performed (imaging studies, urinalysis, etc)
Severity classification (KDIGO stage)
Therapeutic interventions implemented
Clinical and laboratory evolution
Resolution or progression of renal dysfunction

The record should allow another professional, upon reviewing the medical record, to clearly understand why the diagnosis of AKI was established and how the criteria were met.

6. Complete Practical Example

Clinical Case

A 68-year-old female patient, previously healthy, is admitted to the emergency department with a 4-day history of profuse watery diarrhea, frequent vomiting, and progressive reduction in oral intake. She reports that over the last 2 days she has noticed a marked decrease in urine output.

On physical examination: dehydrated (dry mucous membranes, decreased skin turgor), blood pressure 90/60 mmHg, heart rate 110 bpm, current weight 58 kg (reported usual weight 65 kg). Laboratory tests on admission: serum creatinine 3.8 mg/dl, urea 142 mg/dl, sodium 148 mEq/L, potassium 5.2 mEq/L. Outpatient records from 3 months ago show creatinine of 0.9 mg/dl.

During the first 6 hours of observation, even after initiation of cautious fluid replacement, total urine output was 140 ml (0.40 ml/kg/h). Renal ultrasound demonstrates kidneys of normal dimensions, without signs of obstruction, with increased cortical echogenicity.

Step-by-Step Coding

Criteria analysis:

Creatinine criterion: The elevation from 0.9 mg/dl to 3.8 mg/dl represents a 4.2-fold increase from baseline value, clearly exceeding the criterion of 1.5-fold. Although the exact interval is not known with precision, the clinical history of 4 days of symptoms makes it presumable that the elevation occurred in less than 7 days.
Urine output criterion: The output of 0.40 ml/kg/h for 6 hours is below the threshold of 0.5 ml/kg/h for 6 hours or more.

Both criteria are satisfied, confirming the diagnosis of acute kidney injury.

Code selected: GB60

Complete justification:

The patient presents with a typical picture of prerenal acute kidney injury secondary to severe volume depletion from gastrointestinal losses. The marked elevation of creatinine (4.2-fold the baseline value) in a temporal context compatible with acute onset (days), associated with sustained oliguria (urine output below 0.5 ml/kg/h for more than 6 hours), fully satisfies the diagnostic criteria established by ICD-11 for GB60.

The absence of prior history of chronic kidney disease, evidenced by normal renal function documented 3 months earlier, excludes GB61. The acute clinical presentation, with well-defined symptom onset only 4 days ago, reinforces the acute nature of renal dysfunction.

The severity classification corresponds to KDIGO stage 3 (increase greater than 3-fold from baseline and creatinine above 4.0 mg/dl), indicating severe AKI.

Applicable complementary codes:

One may consider an additional code for dehydration (5C70) and for acute gastroenteritis, if the specific etiology is identified, characterizing the precipitating cause of AKI.

7. Related Codes and Differentiation

Within the Same Category

GB61: Chronic kidney disease

The fundamental differentiation between GB60 and GB61 is based on temporality and reversibility. GB60 characterizes acute deterioration of renal function, with onset in days to weeks, often reversible with appropriate treatment of the underlying cause. GB61 refers to established renal dysfunction, persistent for 3 months or more, usually irreversible and progressive.

When to use GB61 instead of GB60:

Patient with chronically elevated creatinine (documented for more than 3 months) without recent acute worsening
Evidence of chronic structural kidney disease (atrophic kidneys on ultrasound, persistent proteinuria)
Chronically reduced glomerular filtration rate
Anemia and bone mineral metabolism disorders compatible with CKD

When both can coexist: Patients with known chronic kidney disease (GB61) who develop superimposed acute deterioration (GB60) should receive both codes. Example: diabetic patient with CKD stage 3 (baseline creatinine 2.0 mg/dl) who develops AKI from dehydration (creatinine rising to 4.5 mg/dl in 2 days).

Differential Diagnoses

Pre-renal azotemia without established AKI: Discrete and rapidly reversible elevations of creatinine in the context of mild hypovolemia, which do not meet complete diagnostic criteria, may not justify GB60. Rapid response to hydration (normalization in hours) suggests that true renal injury did not occur.

Acute exacerbation of chronic kidney disease: Distinguishing acute worsening over chronic disease requires documentation of previous baseline renal function. The absence of prior records may hinder differentiation, making it necessary to infer from clinical history, kidney size, and presence of chronic complications.

Pseudorenal insufficiency: Laboratory interference (use of cimetidine, trimethoprim) or states of increased muscle metabolism may elevate creatinine without true renal dysfunction. Evaluation of other markers (cystatin C, creatinine clearance) may help.

8. Differences with ICD-10

In ICD-10, acute kidney injury was coded as N17, with subdivisions: N17.0 (AKI with tubular necrosis), N17.1 (AKI with acute cortical necrosis), N17.2 (AKI with medullary necrosis), N17.8 (other AKI) and N17.9 (AKI unspecified).

The main change in ICD-11 with code GB60 is the simplification and unification under a single code, without mandatory subdivisions based on specific histopathological findings. This modification reflects the clinical reality where renal biopsy is rarely performed in cases of AKI, and etiological classification is based predominantly on non-invasive clinical and laboratory criteria.

ICD-11 incorporates KDIGO diagnostic criteria directly into the official definition, standardizing internationally what constitutes AKI. In ICD-10, diagnostic criteria were not explicitly defined in the classification, generating interpretive variability.

The practical impact of these changes includes greater uniformity in coding across different institutions and countries, facilitation of comparative epidemiological studies, and alignment with contemporary clinical guidelines. Coding becomes more objective, based on clearly defined measurable parameters.

Professionals familiar with ICD-10 should understand that GB60 essentially encompasses all cases previously coded as N17.x, eliminating the need for distinction between histopathological subtypes in routine coding.

9. Frequently Asked Questions

1. How is acute kidney injury diagnosed?

Diagnosis is based on objective laboratory and clinical criteria. Serum creatinine is measured, comparing it with previous or presumed baseline values. An increase of 0.3 mg/dl or more within 48 hours, or elevation of 1.5 times or more the baseline value within up to 7 days is verified. In parallel, urine output is monitored rigorously: volume less than 0.5 ml/kg/h sustained for 6 hours or more characterizes AKI. Complementary tests include urinalysis, electrolytes, urea, renal ultrasound, and investigation of the underlying cause.

2. Is treatment available in public health systems?

Treatment of acute kidney injury is considered essential and is generally available in public health systems, although accessibility may vary depending on region and local resources. Management includes supportive measures (hydration, correction of electrolyte disturbances, adjustment of nephrotoxic medications), treatment of the underlying cause, and in severe cases, renal replacement therapy (hemodialysis or peritoneal dialysis). General hospitals typically have capacity to manage mild to moderate AKI, while severe cases may require transfer to centers with intensive care units and specialized nephrology services.

3. How long does treatment last?

Treatment duration varies widely depending on the severity and etiology of AKI. Mild cases of pre-renal AKI due to dehydration may resolve in 24-72 hours with adequate hydration. AKI due to acute tubular necrosis typically requires 7-14 days for renal function recovery, potentially extending for weeks in severe cases. Patients requiring dialysis may need support for days to weeks, with some developing prolonged or permanent dialysis dependence. Approximately 50-70% of patients with AKI recover sufficient renal function for dialysis independence, but recovery time is unpredictable.

4. Can this code be used in medical certificates?

Yes, code GB60 can and should be used in medical certificates when appropriate. Acute kidney injury constitutes a serious medical condition that justifies temporary work leave during the acute phase and recovery. Duration of leave varies depending on severity: mild cases may require only a few days, while severe cases requiring dialysis may justify leave for weeks. Documentation should include the ICD-11 code GB60, description of severity, and estimated time needed for recovery, based on individual clinical evolution.

5. Does AKI always progress to chronic kidney disease?

No. Most cases of AKI, especially those diagnosed and treated early, show complete or near-complete recovery of renal function. However, episodes of severe AKI, recurrent AKI, or AKI in patients with risk factors (diabetes, hypertension, advanced age, previous kidney disease) may result in residual kidney injury and progression to chronic kidney disease. Studies indicate that approximately 20-30% of survivors of severe AKI develop some degree of subsequent chronic renal dysfunction. Nephrology follow-up after an AKI episode is recommended to monitor recovery and detect progression.

6. Which medications should be avoided during AKI?

Various medications require dose adjustment or discontinuation during AKI. Nonsteroidal anti-inflammatory drugs should be avoided as they reduce renal perfusion. Nephrotoxic antibiotics (aminoglycosides, vancomycin) require rigorous dose adjustment with monitoring of serum levels. Iodinated radiologic contrast should be postponed when possible. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are frequently suspended temporarily. Diuretics should be reassessed. Medications with predominantly renal elimination require dose adjustment to prevent toxic accumulation. Complete pharmacological review is essential in AKI management.

7. When is dialysis necessary in AKI?

Absolute indications for dialysis include: hyperkalemia refractory to clinical treatment (potassium greater than 6.5-7.0 mEq/L with electrocardiographic changes), severe refractory metabolic acidosis, volume overload with pulmonary edema unresponsive to diuretics, signs of uremia (uremic pericarditis, uremic encephalopathy, uremic bleeding), and intoxications by dialyzable substances. Relative indications include very elevated urea (above 150-200 mg/dl), persistent oliguria/anuria, and need for administration of large volumes (nutrition, medications) in an oliguric patient. The decision considers multiple clinical and laboratory factors.

8. What is the difference between AKI and acute kidney injury?

The terms "acute kidney injury" and "acute kidney injury" are frequently used interchangeably in contemporary clinical practice, both referring to the same spectrum of conditions characterized by abrupt decline in renal function. The nomenclature "acute kidney injury" (Acute Kidney Injury - AKI) has been preferred in recent medical literature as it emphasizes that detectable alterations may occur before frank "insufficiency," allowing for earlier intervention. For ICD-11 coding purposes, GB60 encompasses the entire spectrum, from initial alterations to established insufficiency, provided that diagnostic criteria are present.

Conclusion

Accurate coding of acute kidney injury using GB60 requires clear understanding of objective diagnostic criteria, appropriate differentiation of chronic conditions, and detailed documentation. Correct application of this code facilitates appropriate clinical management, enables reliable epidemiological tracking, and contributes to continuous improvement in quality of care for patients with this potentially serious but frequently reversible condition.

External References

This article was developed based on reliable scientific sources:

🌍 WHO ICD-11 - Acute kidney injury
🔬 PubMed Research on Acute kidney injury
🌍 WHO Health Topics
📊 Clinical Evidence: Acute kidney injury
📋 Ministry of Health - Brazil
📊 Cochrane Systematic Reviews

References verified on 2026-02-03

Acute Kidney Injury

Share